SCM
Silverarc Capital Management Portfolio holdings
AUM
$489M
This Quarter Return
-0.75%
1 Year Return
+71.55%
3 Year Return
+1,109.63%
5 Year Return
–
10 Year Return
–
AUM
$211K
AUM Growth
+$211K
(-100%)
Cap. Flow
-$26.3M
Cap. Flow
% of AUM
-12,436.59%
Top 10 Holdings %
Top 10 Hldgs %
55.44%
Holding
84
New
12
Increased
41
Reduced
10
Closed
15
Top Buys
| 1 |
Athira Pharma
ATHA
|
$27K |
| 2 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$8.06K |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$6.97K |
| 4 |
Veracyte
VCYT
|
$5.63K |
| 5 |
Apellis Pharmaceuticals
APLS
|
$5.35K |
Top Sells
| 1 |
RACB
Research Alliance Corp. II Class A Common Stock
RACB
|
$5.42M |
| 2 |
Halozyme
HALO
|
$2.86M |
| 3 |
Cytokinetics
CYTK
|
$2.65M |
| 4 |
Aurinia Pharmaceuticals
AUPH
|
$2.29M |
| 5 |
BridgeBio Pharma
BBIO
|
$1.67M |
Sector Composition
| 1 | Healthcare | 98.52% |
| 2 | Financials | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Athira Pharma
ATHA
$15.3M
| $27K | 11.16% | +10,000 | New | +$27K |
|
|
ITCI
2
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $18.9K | 7.82% | 308,819 +113,819 | +58% | +$6.97K |
|
|
SRRA
3
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $14.2K | 5.88% | 443,381 +251,336 | +131% | +$8.06K |
|
|
4
Veracyte
VCYT
$2.39B
| $11.7K | 4.86% | 425,554 +204,192 | +92% | +$5.63K |
|
|
CTIC
5
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $10.5K | 4.35% | 2,250,000 +766,171 | +52% | +$3.58K |
|
6
Merus
MRUS
$4.98B
| $8.59K | 3.55% | 324,719 +4,545 | +1% | +$120 |
|
7
Cerus
CERS
$251M
| $7.68K | 3.18% | 1,398,400 +355,678 | +34% | +$1.95K |
|
|
HZNP
8
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $7.1K | 2.94% | 67,442 +5,742 | +9% | +$604 |
|
|
APEN
9
DELISTED
Apollo Endosurgery, Inc.
APEN
| $6.08K | 2.51% | 1,004,399 +264,795 | +36% | +$1.6K |
|
|
10
Apellis Pharmaceuticals
APLS
$3.48B
| $5.35K | 2.22% | +105,368 | New | +$5.35K |
|
11
Aclaris Therapeutics
ACRS
$209M
| $4.75K | 1.96% | 275,333 -10,893 | -4% | -$188 |
|
12
iTeos Therapeutics
ITOS
| $4.47K | 1.85% | 138,843 +837 | +0.6% | +$27 |
|
|
BHVN
13
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $4.36K | 1.8% | 102,497 +22,149 | +28% | +$942 |
|
14
Cogent Biosciences
COGT
$1.69B
| $4.3K | 1.78% | 573,699 -277,236 | -33% | -$2.08K |
|
|
MRTX
15
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $3.79K | 1.57% | 46,122 -14,635 | -24% | -$1.2K |
|
16
Immatics
IMTX
$619M
| $3.56K | 1.47% | 445,334 +54,179 | +14% | +$433 |
|
17
Krystal Biotech
KRYS
$4.27B
| $3.09K | 1.28% | 46,489 -181 | -0.4% | -$12 |
|
|
IMGN
18
DELISTED
Immunogen Inc
IMGN
| $3.07K | 1.27% | 645,000 -869,411 | -57% | -$4.14K |
|
|
NGM
19
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $3.06K | 1.27% | +200,494 | New | +$3.06K |
|
|
OTIC
20
DELISTED
Otonomy, Inc.
OTIC
| $2.9K | 1.2% | 1,207,385 +7,571 | +0.6% | +$18 |
|
|
MORF
21
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $2.76K | 1.14% | 68,709 +1,269 | +2% | +$51 |
|
22
United Therapeutics
UTHR
$13.8B
| $2.66K | 1.1% | 14,836 +285 | +2% | +$51 |
|
23
Galapagos
GLPG
$2.07B
| $2.54K | 1.05% | 41,002 -87,899 | -68% | -$5.45K |
|
24
Crinetics Pharmaceuticals
CRNX
$2.92B
| $2.5K | 1.04% | 114,004 +2,144 | +2% | +$47 |
|
25
Insmed
INSM
$28.8B
| $2.4K | 0.99% | 102,067 +1,446 | +1% | +$34 |
|